Association Between Chronic Obstructive Pulmonary Disease and Mortality in Participants with Arthritis: Data from the National Health and Nutrition Examination Survey 1999-2018.
Autor: | Zhang Y; Department of Laboratory Medicine, Affiliated Wuxi Fifth Hospital of Jiangnan University, Wuxi, China., Chen G; Respiratory and Critical Care Medicine, the Second People's Hospital of Banan District, Chongqing, China., Huang A; Respiratory and Critical Care Medicine, the Second People's Hospital of Banan District, Chongqing, China., Hu Y; Respiratory and Critical Care Medicine, the Second People's Hospital of Banan District, Chongqing, China., Fu C; Respiratory and Critical Care Medicine, the Second People's Hospital of Banan District, Chongqing, China.; Department of Respiratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2024 Dec 13. Date of Electronic Publication: 2024 Dec 13. |
DOI: | 10.15326/jcopdf.2024.0573 |
Abstrakt: | Objective: Chronic obstructive pulmonary disease (COPD) is closely associated with arthritis. This study aims to evaluate the correlation between COPD and mortality among participants with arthritis. Methods: The study included 11,298 participants from the National Health and Nutrition Examination Survey (NHANES) 1999-2018, who self-reported having arthritis. Cox proportional hazards models were used to assess the association between COPD and mortality among participants with arthritis. Kaplan-Meier survival curves were plotted to compare survival probabilities between groups. Subgroup and sensitivity analyses were conducted to assess the robustness of the results. Results: During an average follow-up of 8.8 years, 3,061 all-cause deaths were observed, including 1,024 related to cardiovascular disease (CVD). After weighted multivariable adjustment, COPD was found to be significantly associated with both all-cause and CVD mortality among these arthritis participants. The hazard ratio (HR) for all-cause mortality among arthritis patients with COPD was 1.41 (95% CI: 1.25-1.60, p < 0.001), and the HR for CVD mortality was 1.29 (95% CI: 1.08-1.53, p < 0.001). Kaplan-Meier survival curves attributed higher rates of both all-cause and CVD mortality among participants with COPD compared to those without (log-rank test, p < 0.001). Additionally, COPD increased the risk of both chronic lower respiratory diseases (CLRD) mortality (HR 5.46, 95% CI: 3.48-8.56, p < 0.001) and non-CLRD mortality (HR 1.24, 95% CI: 1.07-1.44, p = 0.004). Conclusion: In the American population, arthritis patients with COPD have higher risks of all-cause and CVD mortality compared to those without COPD. (JCOPDF © 2024.) |
Databáze: | MEDLINE |
Externí odkaz: |